GEN3014 (HexaBody®-CD38) versus daratumumab in patients with relapsed/ refractory multiple myeloma: design of randomized head-to-head expansion cohort of phase 1/2 trial

Sebastian Grosicki, Binod Dhakal, Ehsan Malek, Maria Creignou, Wojciech Jurczak, Annemiek Broijl, Katrine Fladeland Iversen, Henrik Gregersen, Jakub Radocha, Jenny Chen, Adeleye Ogunkanmi, Andrew Spencer

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerP-050
TidsskriftClinical Lymphoma, Myeloma & Leukemia
Vol/bind2
Udgave nummerSuppl. 2
Sider (fra-til)S62-S63
ISSN2152-2650
StatusUdgivet - sep. 2023
Begivenhed20th International Myeloma Society Annual Meeting and Exposition - Megaron Athens International Conference Centre, Athen, Grækenland
Varighed: 27 sep. 202330 sep. 2023
https://www.myelomasociety.org/events/20th-ims-annual-meeting/

Konference

Konference20th International Myeloma Society Annual Meeting and Exposition
LokationMegaron Athens International Conference Centre
Land/OmrådeGrækenland
ByAthen
Periode27/09/202330/09/2023
Internetadresse

Bibliografisk note

Abstrakt No. P-050

Citationsformater